69 related articles for article (PubMed ID: 8619692)
1. Monitoring of systemic anticoagulation during cardiopulmonary bypass.
Bidstrup BP
Ann Thorac Surg; 1996 Mar; 61(3):781-2. PubMed ID: 8619692
[No Abstract] [Full Text] [Related]
2. Management of anticoagulation for coronary artery bypass surgery in a patient with severe prekallikrein deficiency.
Oram MP; Mumford AD; Morse C; Underwood S
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):580-2. PubMed ID: 16884995
[No Abstract] [Full Text] [Related]
3. Extrinsic pathway--associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass.
Gu YJ; Huyzen RJ; van Oeveren W
Anesth Analg; 1996 Aug; 83(2):433. PubMed ID: 8694335
[No Abstract] [Full Text] [Related]
4. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
5. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients].
Jiang L; Yu JF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611
[TBL] [Abstract][Full Text] [Related]
7. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
8. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
Despotis GJ; Alsoufiev AL; Spitznagel E; Goodnough LT; Lappas DG
Ann Thorac Surg; 1996 Mar; 61(3):795-9. PubMed ID: 8619695
[TBL] [Abstract][Full Text] [Related]
9. [Anticoagulant therapy and cardiopulmonary bypass].
Lespron Robles Mdel C; Molina Méndez J
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-185-93. PubMed ID: 18938724
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation policy during use of aprotinin in cardiopulmonary bypass.
van Oeveren W; van Oeveren B; Wildevuur CR
J Thorac Cardiovasc Surg; 1992 Jul; 104(1):210-1. PubMed ID: 1377314
[No Abstract] [Full Text] [Related]
11. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
Spinler SA; Wittkowsky AK; Nutescu EA; Smythe MA
Ann Pharmacother; 2005; 39(7-8):1275-85. PubMed ID: 15956240
[TBL] [Abstract][Full Text] [Related]
12. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
15. Baboon veno-arterial cardiopulmonary bypass without anticoagulants.
Fletcher JR; McKee A; Anderson R; Watson L
Trans Am Soc Artif Intern Organs; 1978; 24():315-9. PubMed ID: 102058
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring heparin for anticoagulation during cardiopulmonary bypass].
Li LH
Zhonghua Xin Xue Guan Bing Za Zhi; 1982 Dec; 10(4):251-5. PubMed ID: 7160291
[No Abstract] [Full Text] [Related]
17. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
18. [Heparin resistance during cardiopulmonary bypass].
Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
[TBL] [Abstract][Full Text] [Related]
19. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
Yamanishi H; Watanabe S; Hayashi K; Tomioka H; Minami M; Nozaki Y; Aoki T; Kawai Y; Kishino K; Ohta S
Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
[TBL] [Abstract][Full Text] [Related]
20. Does preoperative level of antithrombin III predict heparin resistance during extracorporeal circulation?
Rodríguez-López JM; del Barrio E; Lozano FS; Muriel C
Anesth Analg; 2008 Oct; 107(4):1444-5. PubMed ID: 18806070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
